One Health Approach to Rabies Elimination in India: Progress, Operational Bottlenecks, and Innovative Interventions
Description
Dog-mediated human rabies continues to be one of the most inequitably distributed vaccine-
preventable zoonoses of our time, and India has historically carried a disproportionate share of this global
burden. The launch of the National Action Plan for Rabies Elimination by 2030 (NAPRE 2030) marked a
deliberate policy shift away from siloed, reactive, sector-specific responses toward an operationalised One
Health framework that binds together human health authorities, veterinary and animal husbandry
departments, urban local bodies, and forest and wildlife agencies under a common elimination target. This
review synthesises the evolving epidemiological picture, the policy architecture of NAPRE 2030, the
persistent ground-level operational bottlenecks that slow programme delivery, and the technological and
biomedical innovations now reshaping the Indian rabies-control landscape. Importantly, this update
incorporates the most recent nationally representative estimate of disease burden — a 2022–23
community-based decision-tree modelling survey that places annual human rabies mortality in India at
approximately 5,726 deaths, a substantial downward revision from the long-cited figure of nearly 20,000
deaths, reflecting both genuine programmatic gains and improved epidemiological measurement. Ground-
level constraints discussed include unmanaged free-roaming dog (FRD) demography sustained by open
municipal solid waste, structural and financial limits on Animal Birth Control (ABC)/Catch-Neuter-
Vaccinate-Release (CNVR) programmes, rural cold-chain fragility, chronic Rabies Immunoglobulin (RIG)
supply deficits, and socio-culturally embedded delays in wound care. Against these constraints, the review
evaluates a cluster of converging innovations — Oral Rabies Vaccination (ORV) sachets for catch-resistant
dogs, recombinant human monoclonal antibodies (mAbs) progressively displacing serum-derived
immunoglobulins, WHO-endorsed one-week intradermal (ID) dose-sparing post-exposure prophylaxis
(PEP), digital and mobile spatial surveillance platforms, next-generation messenger RNA (mRNA) and self-
amplifying RNA rabies vaccine candidates, and unmanned aerial vehicle (UAV)-assisted last-mile biologic
delivery. Field-validated regional models from Goa and Sikkim are examined as proof of operational
concept for the Indian socio-ecological setting. The review concludes with a set of strategic, resource-
conscious recommendations — institutional, financial, and community-facing — necessary if India is to
convert the stated ambition of NAPRE 2030 into a verified, internationally recognised elimination of dog-
mediated human rabies.